Results announced at HIV conference show BIT225 stops virus spreading. [ + ]

Gene, ABCA13, has been found to be linked to schizophrenia and bipolar disorder. [ + ]

Manufacturing and social innovation are the focus of the latest Cooperative Research Centres (CRC) Program selection round.

University of Reading researchers suggest that two glasses of Champagne a day may be good for your heart and circulation.

Laboratory experiments suggest that myrrh, a resin obtained from several species of Commiphora and Balsamodendron trees, may have cholesterol-lowering properties.

Two Australian research teams have been awarded $50 million to develop a bionic eye.

Ian Olver, CEO of Cancer Council Australia, and Trevor Davies, of the Institute of Patent and Trade Mark Attorneys of Australia, debate the merits and dangers of gene patents. [ + ]

CSL has announced that a vaccine to treat severe gum disease is being developed in a new collaboration with Sanofi Pasteur.

Australian R&D firm delivers first of 3D bio-printer to Organovo using latter's NovoGen technology.

The Caribbean sun anemone disables its prey with a potent neurotoxin that could provide a new treatment for the disabling auto-immune disorder, multiple sclerosis. [ + ]

NHMRC lifts moratorium on xenotransplantation in Australia, LCT aims to begin trials. [ + ]

Pilot study shows afamelanotide improves quality of life in cancer patients. [ + ]

Treatment could help improve blood flow and decrease tissue death in individuals with diabetes. [ + ]

CLS, Cochlear, ResMed, Ansell, Living Cell Technology, Ramsay Health Care, ChemGenex [ + ]

The ECHA Member State Committee has identified 15 new chemical substances for the Candidate List of substances of very high concern which will be added to the Candidate List in January 2010.